Navigation Links
SCD-iBIO Announces Second International Forum on Commercializing Global Green

WASHINGTON, Aug. 22, 2013 /PRNewswire-USNewswire/ -- SCD-iBIO, an industrial biotechnology focused group affiliated with the Society of Chemical Manufacturers and Affiliates (SOCMA), today announced that the Second International Forum on Commercializing Global Green: Markets from the Value Chain Perspective will be held November 11-13, 2013, at the Chemical Heritage Foundation (CHF) in Philadelphia, PA.

SCD-iBIO organized the forum to address the broad range of markets industrial biotechnology penetrates and discuss key issues facing the industry, such as shale gas and gas liquids. 

"The advent of shale gas and gas liquids has changed the landscape of chemical production and products," said William B. Armiger, Ph.D., Executive Director of SCD-iBIO and President of BioChemInsights, Inc. "Petroleum feedstocks (specifically naphtha) previously were used, but now natural gas liquids like ethane and propane are taking its place. Because of the feedstock change, industrial biotechnology is being asked to complement natural gas liquid-based production with products that would normally come from naphtha-based steam crackers. Attendees at our meeting will go away with a better understanding of what the future holds for partnerships between shale gas and industrial biotechnology," he said.

The three-day interactive event will include not only in-depth discussions but opportunities to network and form new professional relationships. End markets that will be highlighted include packaging, automotive, advanced biofuels and personal care, as well as intermediate markets for coatings, adhesives and sealants. The forum offers attendees an opportunity to ask questions, express opinions and widen their perspectives.

"Our forums bring together companies along the entire iBIO value chain from raw materials to commercial brands in an intimate and interactive environment where they can gain an in-depth understanding of the market forces and technological advances driving business growth," Armiger said.

About SCD-iBIO

SCD-iBO, an affiliate of SOCMA, is a company member organization that advances the commercial development of industrial biotechnology, which is the application of biology for the environmentally friendly and economically sustainable production and processing of chemicals, plastics, materials and energy. SCD-iBIO provides its members access to the latest technical knowledge in industrial biotechnology combined with the best business practices for commercial development. With industrial biotechnology rapidly emerging as a key technology for economic growth on a global-scale, SCD-iBIO supports its members' common goal of creating a sustainable chemical industry meeting the needs of the 21st century.

Jenny Gaines
Manager, Public Relations & Media
(202) 721-4123

SOURCE Society of Chemical Manufacturers and Affiliates
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. SOCMA Announces Launch of SCD-iBIO Group
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
5. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
6. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
7. WuXi PharmaTech Announces Third-Quarter 2011 Results
8. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
9. Spherix Announces Third Quarter Financial Results
10. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
11. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):